This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CASMED Reports Second Quarter 2010 And Year-to-Date Financial Results

  • FORE-SIGHT revenue for quarter increased by 41% over second quarter of 2009.
  • Balance sheet strengthened by $2.0 million of cash from operations year-to-date and $1.9 million private placement.

BRANFORD, Conn., Aug. 4, 2010 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today reported second quarter 2010 revenues of $8.2 million, a decrease of $0.4 million, or 4%, compared to revenues of $8.6 million for the second quarter of 2009. The Company reported net income of $8,000, or $0.00 per basic and diluted common share, compared to a net loss of $0.8 million, or ($0.07) per basic and diluted common share, reported for the second quarter of the prior year.

Revenues for the second quarter ended June 30, 2010 were led by increased sales of the Company's FORE-SIGHT ® Absolute Oximeter monitors and sensors. These increases were offset by reductions in sales of certain discontinued products in bedside monitoring and blood pressure cuffs. FORE-SIGHT sales were $1.4 million for the second quarter of 2010, an increase of $0.4 million, or 41%, over the $1.0 million reported for the second quarter of 2009.

Operating income was $13,000 for the second quarter of 2010, compared to an operating loss of $1.2 million for the same period of the prior year, and was generated by improved gross profit levels and lower operating expenses. Gross profit levels as a percentage of sales increased to 38% from 30%, and operating expenses as a percentage of sales improved to 38% from 44% when comparing the second quarter of 2010 to the second quarter of 2009. Gross profits were affected by favorable product mix, including the discontinuation of less profitable product lines, and reduced manufacturing overhead spending and variances. Personnel reductions implemented during 2009, along with other cost cutting measures, were primarily responsible for the reduction in operating expenses of $0.6 million to $3.2 million for the second quarter of 2010 from $3.8 million reported for the second quarter of 2009.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CASM $1.30 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs